s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
D
Exempt (Private) Offering
Filed
Friday, April 11, 2025
Accession number
0001641172-25-003828
Documents
primary_doc.xml
D
On sec.gov
Filing index
All files
Complete submission text
SGML header